Indanyl-piperazine compounds
US7442692B2 · kind B2 · utility
0Cited by
0References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 29, 2006 |
| Grant date | Oct 28, 2008 |
| Priority date | — |
| Expiry date | Dec 19, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D333/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound selected from those of formula (I):wherein: Medical products containing the same which are useful in the treatment of conditions requiring a serotonin reuptake inhibitor and/or NK1 antagonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.